NEW YORK -- Obagi Medical, a company that specializes in advanced skincare innovation and the originator of medical-grade skincare, has introduced CLENZIderm M.D. Resurfacing Multi-Acid Peel Pads.
"Effective exfoliation is the foundation of optimal skin health," said Dr. Suzan Obagi. "These peel pads make it easy to build consistent, targeted exfoliation into a PM routine, helping reveal visibly smoother, brighter, more even-toned skin over time."
The CLENZIderm M.D. Resurfacing Multi-Acid Peel Pads are formulated with a blend of Glycolic, Phytic, Salicylic and Mandelic acids, which have been selected for targeted action at different layers of skin. These acids deliver multi-tiered exfoliation that is meant to smooth skin texture, reduces the look of discoloration, decongests and minimizes the appearance of pores, as well as visible brightens dull skin for a more even-tones, radiant complexion.
"We're committed to developing clinically proven skincare solutions that meet the evolving needs of both providers and patients," said Dorothée Dufour, Senior Vice President of Global & Brand Marketing. "These peel pads mark an exciting expansion of the CLENZIderm M.D.® franchise, giving consumers an easy, one-step way to bring dermatologist-trusted resurfacing into their everyday routine."
According to a release from Obagi Medical, in a clinical study 97% of participants agreed the CLENZIderm M.D. Resurfacing Multi-Acid Peel Pads visibly smoothed skin texture after four weeks. By eight weeks, 90% noticed their skin looked smoother, 83% saw their breakouts and blemishes improve, and the majority of participants noticed brighter-looking skin with a reduced appearance of post-blemish marks.
